Source:http://linkedlifedata.com/resource/pubmed/id/10720899
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2000-5-16
|
pubmed:abstractText |
The kidney function in a model of autosomal dominant polycystic kidney disease (PKD), the Han:SPRD rat, is dramatically improved by chronic ingestion of a solution of potassium citrate and citric acid (KCitr). This study investigated whether this treatment would also be beneficial in the pcy/pcy mouse, a model of autosomal recessive PKD. Starting at 1 month of age, male CD-1 pcy/pcy and normal CD-1 mice were provided with a solution of 55 mM K(3) citrate/67 mM citric acid or tap water to drink. The pcy/pcy mice on the KCitr solution failed to grow normally and showed elevated plasma urea levels when compared to water-drinking littermates. Growth of normal CD-1 mice was not affected by KCitr intake. The pcy/pcy mice were then provided with a more dilute solution of KCitr to drink: this resulted in greater kidney wet and dry weights and a higher kidney weight/body weight ratio, but no beneficial effects. We conclude that pcy/pcy mice cannot tolerate a high level of KCitr intake and that a lower level is of no benefit. Whether KCitr therapy would be helpful in patients with PKD is still an open question.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Chelating Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Citric Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Diuretics,
http://linkedlifedata.com/resource/pubmed/chemical/Potassium Citrate,
http://linkedlifedata.com/resource/pubmed/chemical/Urea
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0028-2766
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright 2000 S. Karger AG, Basel
|
pubmed:issnType |
Print
|
pubmed:volume |
84
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
270-3
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:10720899-Animals,
pubmed-meshheading:10720899-Body Weight,
pubmed-meshheading:10720899-Chelating Agents,
pubmed-meshheading:10720899-Citric Acid,
pubmed-meshheading:10720899-Disease Models, Animal,
pubmed-meshheading:10720899-Diuretics,
pubmed-meshheading:10720899-Female,
pubmed-meshheading:10720899-Glomerular Filtration Rate,
pubmed-meshheading:10720899-Kidney,
pubmed-meshheading:10720899-Male,
pubmed-meshheading:10720899-Mice,
pubmed-meshheading:10720899-Mice, Inbred Strains,
pubmed-meshheading:10720899-Organ Size,
pubmed-meshheading:10720899-Polycystic Kidney, Autosomal Recessive,
pubmed-meshheading:10720899-Potassium Citrate,
pubmed-meshheading:10720899-Urea
|
pubmed:year |
2000
|
pubmed:articleTitle |
Effects of potassium citrate/citric acid intake in a mouse model of polycystic kidney disease.
|
pubmed:affiliation |
Department of Physiology and Biophysics, Indiana University School of Medicine, Indianapolis, IN 46202, USA. gtanner@iupui.edu
|
pubmed:publicationType |
Journal Article
|